KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Invested Capital (2016 - 2025)

Historic Invested Capital for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $63.3 billion.

  • Amgen's Invested Capital fell 411.36% to $63.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $63.3 billion, marking a year-over-year decrease of 411.36%. This contributed to the annual value of $63.3 billion for FY2025, which is 411.36% down from last year.
  • As of Q4 2025, Amgen's Invested Capital stood at $63.3 billion, which was down 411.36% from $64.2 billion recorded in Q3 2025.
  • In the past 5 years, Amgen's Invested Capital registered a high of $70.8 billion during Q4 2023, and its lowest value of $37.8 billion during Q1 2022.
  • Moreover, its 5-year median value for Invested Capital was $63.6 billion (2025), whereas its average is $56.6 billion.
  • In the last 5 years, Amgen's Invested Capital plummeted by 1003.47% in 2022 and then surged by 7703.62% in 2023.
  • Amgen's Invested Capital (Quarter) stood at $40.0 billion in 2021, then increased by 6.49% to $42.6 billion in 2022, then surged by 66.28% to $70.8 billion in 2023, then fell by 6.87% to $66.0 billion in 2024, then fell by 4.11% to $63.3 billion in 2025.
  • Its last three reported values are $63.3 billion in Q4 2025, $64.2 billion for Q3 2025, and $63.6 billion during Q2 2025.